QUICKI helps estimate insulin sensitivity, which can guide conversations about metabolic health and diabetes risk. It’s useful for people with weight concerns, prediabetes risk, polycystic ovary syndrome, or fatty liver, and for tracking changes over time. Clinicians often interpret it alongside standard tests like glucose and HbA1c; it is not used alone to diagnose. You can test this marker with Aniva across Germany and Finland.

QUICKI helps estimate insulin sensitivity, which can guide conversations about metabolic health and diabetes risk. It’s useful for people with weight concerns, prediabetes risk, polycystic ovary syndrome, or fatty liver, and for tracking changes over time. Clinicians often interpret it alongside standard tests like glucose and HbA1c; it is not used alone to diagnose. You can test this marker with Aniva across Germany and Finland.

High: Suggests better insulin sensitivity. Maintain healthy habits and monitor trends over time.
Low: Suggests reduced insulin sensitivity. Consider follow-up with standard tests (glucose, HbA1c, or an oral glucose tolerance test) and review medications and lifestyle. Trends over time are more helpful than a single reading.

• Fasting insulin
• Fasting plasma glucose
• HbA1c
• HOMA-IR
• Oral Glucose Tolerance Test

Common factors that can skew results include eating or drinking (other than water) before the test, recent heavy exercise, alcohol, acute illness, poor sleep, and dehydration. Medications like steroids, some antipsychotics, beta blockers, thiazide diuretics, and niacin can affect glucose and insulin. High-dose biotin may interfere with some insulin immunoassays. Pregnancy, insulin therapy, and major weight change can shift values. Use the same lab and time of day when possible.

Special situations: If results don’t fit your symptoms, confirm with standard tests (glucose, HbA1c, or an oral glucose tolerance test) and review medications with your clinician.